BTII Institute Extends Scaled Agile Inc. Partnership
WEST ORANGE, N.J., April 16, 2024 /PRNewswire/ -- BTII Institute, a top Product/Portfolio/Program/Project Management training and consulting services provider, is pleased to announce the extension of its Scaled Agile Inc. Silver Partnership. As an early adopter of SAFe and nearly a decade of dedicated service in delivering Scaled Agile Framework (SAFe®) services, BTII Institute remains at the forefront of empowering organizations and individuals with the training, tools, and knowledge needed to thrive in the digital age.
Why should an employer implement SAFe?
SAFe® is the world's leading Enterprise Agile framework, enabling businesses to achieve unparalleled Business Agility. BTII enables employers to better respond to market dynamics and capitalize on emerging opportunities swiftly, fostering a culture of innovation and efficiency to achieve a sustainable competitive advantage. According to Scaled Agile Inc., organizations implementing SAFe typically experience remarkable results, including:
30 ? 75% faster time-to-market
25 ? 75% improvements in quality
20 ? 50% increase in productivity
10 ? 50% increase in employee engagement and job satisfaction
Led by founder and CEO Sharon Bussey, BTII Institute boasts a team of seasoned instructors and consultants with a wealth of industry experience. Sharon's illustrious career, coupled with her MS in Computer Science and MBA from the Wharton School, ensures that the training and consulting services are delivered with the utmost expertise and professionalism. Additionally, BTII Institute offers flexible schedules and many delivery options. Before selecting a training partner, please contact BTII Institute to learn more about our services.
Contact Information: Company: BTII Institute LLC Contact: Ann Jackson Phone: 973-325-9001 Email: [email protected]
Pfizer Inc. and Genmab A/S today announced the U.S. Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with...
Genmab A/S and Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with recurrent or...
Pond Technologies Holdings Inc. (the "Corporation" or "Pond") announces the filing of the audited consolidated financial statements of the Corporation for the twelve months ended December 31, 2023 and the related management's discussion and analysis...
As a veterinarian in Cuba, Xiomara Delgado was used to providing clinical expertise to patients and families. Now retired and living in Miami, the 77-year-old doctor...
ARHT Media Inc. ("ARHT" or the "Company") , announced today that it will be delayed in filing its financial statements, the accompanying management's discussion and analysis, and related documents with respect to the annual filings for the year...
Energizer Holdings, Inc. announced that its Board of Directors declared a dividend on its common stock of $0.30 per share. The dividend will be payable on June 12, 2024 to shareholders of record as of the close of business on May 22, 2024....
